These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11266494)

  • 1. Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations.
    Pollak R; Billstein SA
    J Am Podiatr Med Assoc; 2001 Mar; 91(3):127-31. PubMed ID: 11266494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.
    Smith EB; Stein LF; Fivenson DP; Atillasoy ES
    Int J Dermatol; 2000 Nov; 39(11):861-4. PubMed ID: 11123452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
    Yadav P; Singal A; Pandhi D; Das S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
    Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
    Evans EG; Sigurgeirsson B
    BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbinafine in onychomycosis of the toenail: a novel treatment protocol.
    Watson A; Marley J; Ellis D; Williams T
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):775-9. PubMed ID: 7593777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.
    Faergemann J; Anderson C; Hersle K; Hradil E; Nordin P; Kaaman T; Molin L; Pettersson A
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):750-3. PubMed ID: 7722020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
    Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
    Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial.
    Jennings MB; Pollak R; Harkless LB; Kianifard F; Tavakkol A
    J Am Podiatr Med Assoc; 2006; 96(6):465-73. PubMed ID: 17114599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
    Salo H; Pekurinen M
    Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
    De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine.
    Watson AB; Marley JE; Ellis DH; Williams TG
    Australas J Dermatol; 1998 Feb; 39(1):29-30. PubMed ID: 9529685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for cure following treatment of onychomycosis.
    Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):679-84. PubMed ID: 19929941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.